Posts by Lana Schumacher-Beal, MD
-
Robotic Approach to Lobectomy Safe and Feasible for Stage II–IIIA NSCLC
In a nationwide study, Massachusetts General Hospital researchers found robotic lobectomy for stage II–IIIA non–small cell lung cancer was associated with a lower conversion rate and length of stay than video-assisted thoracoscopic surgery, and all minimally invasive surgery conferred advantages over open surgery.
Biography
Dr. Lana Schumacher-Beal is the Director of Thoracic Robotic Surgery for Massachusetts General Hospital Network and Program Director for Robotic Surgery at Massachusetts General Hospital. Dr. Schumacher received her medical degree from the UCLA School of Medicine in Los Angeles, CA. She completed her surgical internship and residency at Stanford University Hospital in Stanford, CA. and her cardiothoracic fellowship at the University of Pittsburgh Medical Center in Pittsburgh, PA. She also did further training at Memorial Sloan Kettering Cancer Center, NY.
Dr. Schumacher is board certified by the American Board of Surgery and the American Board of Thoracic Surgery. She has extensive experience in minimally invasive approaches to esophageal and lung diseases. Her expertise lies in advancing robotic thoracic techniques for the treatment of lung cancer, esophageal cancer, benign esophageal disorders, and mediastinal diseases. Dr. Schumacher runs a scholarship for the Women in Thoracic Surgery for Robotic surgery training. She also serves on faculty for the American Association for Thoracic Surgery Graham Foundation Robotic Fellowship.
Dr. Schumacher’s research focuses on the outcomes in robotic surgery for lung cancer, using near-infrared imaging for improved lung and esophageal cancer outcomes and lung cancer in women.
Recent honors/distinctions include participation in the 2018 AATS Leadership Academy and 2015 Pittsburgh Hero Award for Innovation in Medicine.